Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Childrens Place Retail Store

Start price
Target price
Perf. (%)
€13.10
16.09.24
-
16.09.25
10.69%
16:34

quelbe60 
16.09.24 50%
buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.37
16.09.24
-
16.09.25
2.19%
17.09.24

bundfuture 
16.09.24 50%
buy
Immatics N.v.

Start price
Target price
Perf. (%)
€11.58
16.09.24
-
16.09.25
-5.01%
16:17

daimler1 
16.09.24 50%
buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.30
16.09.24
-
16.09.25
-0.97%
17.09.24

daimler1 
16.09.24 50%
buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€3.76
16.09.24
-
16.09.25
-1.86%
15:44

Could be worthwhile Investment >10% per year
daimler1 
16.09.24 50%
buy
Western Uranium Corp

Start price
Target price
Perf. (%)
€0.98
16.09.24
-
16.09.25
4.27%
17.09.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
robertinio 
16.09.24 100%
buy
Novo-nordisk As

Start price
Target price
Perf. (%)
€123.44
16.09.24
-
16.09.25
-4.23%
18:33

gerihouse 
16.09.24 50%
sell
New Gold Inc.

Start price
Target price
Perf. (%)
€2.80
16.09.24
-
16.09.25
-1.82%
17:58

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
robertinio 
16.09.24 100%
buy
Immatics N.v.

Start price
Target price
Perf. (%)
€11.58
16.09.24
€20.00
31.03.27
-5.01%
16:17

Could be very worthwhile Investment >20% year
BiotechBee 
16.09.24 60%
buy
Viridian Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.40
16.09.24
€25.00
31.01.27
0.00%
17.09.24

Could be very worthwhile Investment >20% year
BiotechBee 
16.09.24 70%
buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.30
16.09.24
€18.00
28.02.27
-0.97%
17.09.24

Could be very worthwhile Investment >20% year
BiotechBee 
16.09.24 50%
buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€3.76
16.09.24
€5.00
30.04.27
-1.86%
15:44

Could be very worthwhile Investment >20% year
BiotechBee 
16.09.24 60%
sell
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.11
15.09.24
-
15.09.25
0.00%
18:27

blaugold 
15.09.24 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€60.96
15.09.24
-
15.09.25
4.54%
18:32

blaugold 
15.09.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.20
15.09.24
-
15.09.25
-5.08%
15:48

blaugold 
15.09.24 50%
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€36.19
15.09.24
-
15.10.24
-0.83%
17:50

QuotationFutures40 
15.09.24 50%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€110.00
15.09.24
€180.00
31.08.27
-1.27%
18:34

Could be very worthwhile Investment >20% year
BiotechBee 
15.09.24 70%
buy
Palo Alto Networks

Start price
Target price
Perf. (%)
€312.95
15.09.24
€320.00
15.09.25
-4.90%
18:33

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
High dividend yield expected
Traumtanz 
15.09.24 50%
buy
NIO Inc.

Start price
Target price
Perf. (%)
€5.04
15.09.24
€5.00
15.09.25
-8.20%
17:16

Known brand
Revenue growth >5% per year expected
Fair valuation
Good rating
Traumtanz 
15.09.24 50%
buy
Dürr AG

Start price
Target price
Perf. (%)
€19.50
15.09.24
€21.00
15.09.25
2.56%
18:15

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
High dividend yield expected
positive Cash Flow expected
Traumtanz 
15.09.24 50%
buy
Sixt SE ST

Start price
Target price
Perf. (%)
€62.65
15.09.24
€65.00
15.09.25
0.80%
18:26

EBIT growth >5% per year expected
Good rating
Valuable balance sheet
Normal challenges to pay loans and raise capital
Traumtanz 
15.09.24 50%
buy
Spotify Technology SA

Start price
Target price
Perf. (%)
€305.20
15.09.24
€310.00
15.09.25
1.70%
18:09

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Traumtanz 
15.09.24 50%
sell
Integrum Ab

Start price
Target price
Perf. (%)
€2.58
15.09.24
-
15.09.25
-3.88%
17.09.24

WatchMen 
15.09.24 50%
sell
Adocia

Start price
Target price
Perf. (%)
€5.65
15.09.24
-
15.09.25
-0.71%
17:12

WatchMen 
15.09.24 50%
sell
Nucana Plc

Start price
Target price
Perf. (%)
€3.40
15.09.24
-
15.09.25
-7.65%
17.09.24

WatchMen 
15.09.24 50%